phasebio.com
This page provides financial reports, corporate updates, and investor resources for PhaseBio Pharmaceuticals,… 🔗
Global Rankeez rank — last updated 01 Sep 2026
Better than 93.4% of the 99,976,913 domains we track
Source breakdown
Rankeez combines several independent public rankings. Here's how phasebio.com scores in each:
| Source | Rank |
|---|---|
| DomCop / OpenPageRank | #7,365,680 |
| CommonCrawl (hyperlink graph) | #6,563,943 |
See how these sources are combined and cross-validated →
Ranking history
phasebio.com's rank across 4 monthly snapshots. ▼ dropped by 1,789,968 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #4,849,725 |
| 2026-08 | #6,139,897 |
| 2026-09 | #6,639,693 |
| 2026-10 | #6,639,693 |
JSON API
{
"phasebio.com": 6639693,
"history": {
"2026-07": 4849725,
"2026-08": 6139897,
"2026-09": 6639693,
"2026-10": 6639693
}
}
GET https://rankeez.com/api/phasebio.com.json · see API docs →
More about phasebio.com
phasebio.com — page content & similar sites →
The Investor Relations website contains information about PhaseBio Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
phasebio.com — full site profile →
WHOIS, tech stack and extended traffic history for phasebio.com.